Venrock Healthcare Capital Partners II, L.P.

13D and 13G Filings

13D/G filings
13G on 3 securities
Location
New York, NY
CIK
0001602264
Form D filings
1 filing
All SEC filings
View on sec.gov
Issuer % of Class Filed
DBV Technologies S.A. 13G/A Amendment 5
DBVT · 23306J309
0% 2/17/2026
Event 12/31/2025
DBV Technologies S.A. 13G/A Amendment 4
DBVT · 23306J309
8.2% 11/14/2025
Event 9/30/2025
Cogent Biosciences, Inc. 13G/A Amendment 7
COGT · 19240Q201
4.2% 8/14/2025
Event 6/30/2025
DBV Technologies S.A. 13G/A Amendment 3
DBVT · 23306J309
9.8% 8/14/2025
Event 6/30/2025
Cogent Biosciences, Inc. 13G/A Amendment 6
COGT · 19240Q201
5.8% 4/11/2025
Event 9/30/2024
Trevi Therapeutics, Inc. 13G/A Amendment 4
TRVI · 89532M101
1.4% 2/14/2025
Event 12/31/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.